SHERI L. TARR is the Founder and Chief Advisor of '68 PARTNERS, a global consulting firm helping life sciences companies, cannabis brands, and licensed operators build sustainable businesses that have a transformative impact on consumers and patients. A former Big pharma sales and marketing executive who commercialized FDA-regulated products worldwide, Sheri has extensive real-world experience operating in highly regulated environments. After working for Fortune 500 pharmaceutical companies, Sheri flipped the script and became an attorney who spent a distinguished career in the courtroom holding these companies accountable for deceptive marketing, defective manufacturing, and other regulatory violations.

Sheri has been in the regulatory trenches for decades. She has witnessed first-hand the good, the bad, and the totally avoidable. Sheri has a unique understanding of the complex business, organizational, and regulatory challenges faced by cannabis stakeholders, and intimately knows the tension between profit and risk. Using her business savvy and regulatory-legal prowess, Sheri works with clients to commercialize products inter- and intra-state, discern regulatory pathways for new market expansion, and develop packaging, labeling, marketing, and advertising that balances compliance with compelling branding.

'68 PARTNERS specializes in full-service license application preparation, regulatory navigation, best compliance practices, and seamless product commercialization. Sheri’s life sciences and cannabis industry insights and guidance has been sought by legislators, regulators, law firms, and other industry stakeholders around the world.

A University of Michigan alumni and Chicago-Kent College of Law, Illinois Institute of Technology graduate, Sheri is a frequent speaker and guest lecturer, and serves on the boards of several life sciences and cannabis companies.